Repeated Dose IV Baclofen Safety/Bioequivalence Study
Clinical trial NCT02760992 · UNKNOWN
Trial details
- NCT number
- NCT02760992
- Sponsor
- Allaysis, LLC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2017-09-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.